Answer
Rifampicin, a strong CYP3A4/5 inducer, may decrease axitinib blood levels; an alternative with no or minimal CYP3A4/5 induction is recommended, or axitinib dose adjustment if co-administration is necessary.
Sources for this answer
- Inlyta 5 mg film-coated tabletsPfizer Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 17Document updated
Sources checked